R

retatrutide

Product

by Eli Lilly and Company

Heard in 43 episodes across 29 shows since Mar 2026

An investigational once-weekly medication that activates GLP-1, GIP, and glucagon receptors and is being studied for obesity, diabetes, and related metabolic conditions.

Discussed inMarkets44%Business18%Politics18%Health & Science15%

Episodes

43
across 29 shows

This week

0
episodes on 0 shows

Expert statements

17
15 positive

Share of the conversation

Mentions of retatrutide per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.1‰0.2‰0.3‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Aug 250.02‰1
Sep 10.03‰3
Sep 30.07‰4
Sep 80.07‰2
Sep 100.05‰3
Sep 140.06‰1
Sep 210.01‰1
Sep 280.02‰2
Oct 10.03‰1
Oct 140.01‰1
Oct 150.02‰1
Oct 160.03‰1
Oct 200.04‰2
Oct 280.06‰7
Oct 290.09‰4
Oct 300.13‰4
Nov 20.21‰10
Nov 30.22‰1
Nov 50.15‰3
Nov 120.02‰2
Nov 130.04‰3
Nov 200.01‰1
Nov 210.04‰4

The full trend: rank, tone and why it is trending →

Email alert

Email me when retatrutide comes up on a podcast

One email a week at most, with the new episodes that mention retatrutide. Free, no account needed, unsubscribe in one click.

What experts have said about retatrutide

17 statements · 15 positive · 1 mixed · 1 neutral

  1. Sam SulekPositiveOct 1, 2026· Modern Wisdom

    Retatrutide is viewed as modifying a normal human process without substantial negative effects.

    “it is just taking an intervention of what you'd call a normal human process without that much of a, in terms of like a negative effect.”

    Listen at 1:30:20

    Open the episode · How To Go Hard, Even When You Don’t Want To - Sam Sulek - #1157
  2. Chris ThompsonPositiveSep 21, 2026· Huberman Lab

    Glucagon activity in retatrutide may preserve muscle during weight loss.

    “glucagon is potential muscle sparing there”

    Listen at 50:54

    Open the episode · Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson
  3. Retatrutide will generate enormous revenue for Lilly

    “retatrutide is going to come out from Lilly, make them billions if not trillions of dollars.”

    Listen at 2:15:10

    Open the episode · #2553 - Andrew Huberman

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

43 episodes featuring retatrutide, newest first